Clinical Scorecard: Study Investigates DR in Native Americans
At a Glance
| Category | Detail |
|---|---|
| Condition | Diabetic Retinopathy (DR) |
| Key Mechanisms | Higher rates of diabetes among indigenous populations; associations with diabetes duration and HbA1c levels. |
| Target Population | American Indians/Alaska Natives (AI/AN) with diabetes |
| Care Setting | Clinical settings utilizing fundus photography or ophthalmic examination |
Key Highlights
- 21% prevalence of any DR in AI/AN patients compared to 20% in non-AI/AN patients.
- Proliferative DR (PDR) observed in 3% of AI/AN patients.
- Vision-threatening DR (VTDR) reported in 3% of AI/AN patients and 5% of non-AI/AN patients.
- HbA1c of at least 8% correlated with increased prevalence of diabetic macular edema (DME).
- Current pooled estimates of DR prevalence are lower than previous NHANES data.
Guideline-Based Recommendations
Diagnosis
- Utilize fundus photography or ophthalmic examination for DR evaluation.
Management
- Implement teleophthalmology and AI-based diagnostics to improve access.
Monitoring & Follow-up
- Regular screening for DR in populations with high diabetes prevalence.
Risks
- Potential underreporting in AI/AN groups due to access barriers.
Patient & Prescribing Data
Adults (≥18 years) with type 1 or type 2 diabetes
Improved diabetes care may contribute to lower DR prevalence.
Clinical Best Practices
- Address barriers to screening and imaging quality in underserved populations.
- Consider age-standardized and diabetes type-specific prevalence assessments.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
